Hemophilia A (Factor VIII Deficiency)
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 35 (6) , 1117-1129
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004–2008)Haemophilia, 2010
- Sites of initial bleeding episodes, mode of delivery and age of diagnosis in babies with haemophilia diagnosed before the age of 2 years: a report from The Centers for Disease Control and Prevention’s (CDC) Universal Data Collection (UDC) projectHaemophilia, 2009
- Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high‐responding inhibitorsJournal of Thrombosis and Haemostasis, 2009
- Risk factors for inhibitor formation in haemophilia: a prevalent case–control studyHaemophilia, 2009
- Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe HemophiliaNew England Journal of Medicine, 2007
- Hemophilia: A Practical Approach to Genetic TestingMayo Clinic Proceedings, 2005
- Home‐based factor infusion therapy and hospitalization for bleeding complications among males with haemophiliaHaemophilia, 2001
- Intracranial and Extracranial Hemorrhages in Newborns With HemophiliaJournal of Pediatric Hematology/Oncology, 1999
- Pharmaco‐economic aspects of inhibitor treatmentEuropean Journal of Haematology, 1998
- Disappearance of inhibitor to factor VIII in HIV‐infected hemophiliacs with progression to AIDS or severe ARCTransfusion, 1989